Development and Validation of a Model to Predict Fast Progression in Glaucoma
Sponsor: Duke University
Terminated
PI moved to another institution
Other terminated trials from Duke University
Other Glaucoma trials with similar outcome
This observational or N/A phase trial investigates Glaucoma and Glaucoma, Suspect and is currently terminated or withdrawn. Duke University leads this study, which shows 13 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Apr 2024 — Jul 2024 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Jul 2023 — Apr 2024 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Sep 2022 — Jul 2023 [monthly]
Enrolling By Invitation
▶ Show 8 earlier versions
-
Dec 2021 — Sep 2022 [monthly]
Enrolling By Invitation
-
Sep 2021 — Dec 2021 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting
-
Apr 2021 — Jun 2021 [monthly]
Not Yet Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Not Yet Recruiting
-
Aug 2020 — Oct 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
- Genentech, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .